Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine


  1. 2015
  2. Published

    Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

    Podlekareva, D., Grint, D., Karpov, I., Rakmanova, A., Mansinho, K., Chentsova, N., Zeltina, I., Losso, M., Parczewski, M., Lundgren, Jens, Mocroft, A., Kirk, Ole & EuroSIDA in EuroCoord, E. I. E., Oct 2015, In: HIV Medicine. 16, 9, p. 533-43 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study

    Raben, D., Mocroft, A., Rayment, M., Mitsura, V. M., Hadziosmanovic, V., Sthoeger, Z. M., Palfreeman, A., Morris, S., Kutsyna, G., Vassilenko, A., Minton, J., Necsoi, C., Estrada, V. P., Grzeszczuk, A., Johansson, V. S., Begovac, J., Ong, E. L. C., Cabié, A., Ajana, F., Celesia, B. M. & 15 others, Maltez, F., Kitchen, M., Comi, L., Dragsted, U. B., Clumeck, N., Gatell, J., Gazzard, B., d'Arminio Monforte, A., Rockstroh, J., Yazdanpanah, Y., Champenois, K., Jakobsen, M. L., Sullivan, A., Lundgren, Jens & HIDES Audit Study Group, H. A. S. G., 11 Nov 2015, In: P L o S One. 10, 11, p. 1-10 e0140845.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Hvordan optimerer vi hiv-testning i Danmark?

    Raben, D. & Lundgren, Jens, 7 Dec 2015, In: Ugeskrift for Laeger. 177, 50, V67906.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    HIV resistance testing and detected drug resistance in Europe

    Schultze, A., Phillips, A. N., Paredes, R., Battegay, M., Rockstroh, J. K., Machala, L., Tomazic, J., Girard, P. M., Januskevica, I., Gronborg-Laut, K., Lundgren, Jens, Cozzi-Lepri, A. & EuroSIDA in EuroCoord, E. I. E., 17 Jul 2015, In: AIDS. 29, 11, p. 1379-89 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

    Sharma, S., Babiker, A. G., Emery, S., Gordin, F. M., Lundgren, Jens, Neaton, J. N., Bakowska, E., Schechter, M., Wiselka, M. J., Wolff, M. J. & International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group, I. N. F. S. I. I. G. H. T. (. S. S. G., Apr 2015, In: HIV Medicine. 16 , Suppl 1, p. 30-6 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data

    Vingerhoets, J., Calvez, V., Flandre, P., Marcelin, A-G., Ceccherini-Silberstein, F., Perno, C-F., Mercedes Santoro, M., Bateson, R., Nelson, M., Cozzi-Lepri, A., Grarup, J., Lundgren, J., Incardona, F., Kaiser, R., Sonnerborg, A., Clotet, B., Paredes, R., Günthard, H. F., Ledergerber, B., Hoogstoel, A. & 5 others, Nijs, S., Tambuyzer, L., Lavreys, L., Opsomer, M. & Etravirine Cohort Study Group, E. C. S. G., May 2015, In: HIV Medicine. 16, 5, p. 297-306 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 Next

ID: 13961